PT-141

PT-141, also known as Bremelanotide, is a synthetic melanocortin receptor agonist developed for research applications in sexual dysfunction and metabolic disorders. This peptide works by activating melanocortin receptors in the central nervous system, potentially influencing sexual arousal and desire pathways. Primarily utilized in preclinical and clinical research settings, PT-141 has been the subject of numerous studies exploring its effects on erectile function and female sexual arousal. The compound demonstrates a unique mechanism distinct from phosphodiesterase inhibitors, offering researchers an alternative avenue for investigating peptide-based therapeutic approaches. PT-141 is supplied as a research-grade peptide for laboratory and biomedical investigation only. All batches undergo rigorous purity verification and quality control testing to meet pharmaceutical research standards. Proper storage in cool conditions and adherence to handling protocols ensure optimal stability and integrity for your research applications.